HopeStage
Back to all studies
WithdrawnNCT01372670

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating disorders

Medication studyAges 8–25United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 8 years to 25 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJanuary 2012
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
HealthPartners Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 8 Years to 25 Years
Official registry ID
NCT01372670
Official title
Show the full official title

Hydroxyzine Effects on Meal-Related Anxiety in Underweight Adolescents and Young Adults Diagnosed With an Eating Disorder - A Pilot Study

Recruitment & locations

Withdrawn

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is HealthPartners Institute, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Hydroxyzine and hydroxyzine HCL.

Who can participate?

Listed age limits: 8 years to 25 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies